News Agency
Men's Weekly

Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO

  • Written by PR Newswire

HONG KONG, Oct. 24, 2023 /PRNewswire/ -- Akeso announced poster presentation at the 2023 European Society for Medical Oncology (ESMO) Congress from its cadonilimab ( PD-1/CTLA-4 bispecific antibody) combined with lenvatinib for first-line treatment of Advanced Hepatocellular Carcinoma (HCC). The principal investigators of the study are Prof. Bai...

Read more: Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of...

Why Furniture Removalists Melbourne Are the Experts You Need for a Smooth Move

Moving house or office is one of life’s most demanding experiences, and one of the most difficult parts of the process is dealing with heavy, bulky, or delicate furniture. From couches and dining tables to antique cabinets and wardrobes, moving... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion